Editor’s Note: A recent piece by Melanie Swan on the Institute for Ethics & Emerging Technologies (ieet.org) suggests that, more than any other industry, stem cell therapies are poised to make a significant near-term impact on worldwide public health. In addition to the most obvious use of stem cells, Swan also acknowledges their value in disease modeling, drug discovery and drug toxicity assessment, and examines policy issues and, what she deems, broken public health and drug development models. To read the article, click here.